Concepedia

Isabelle Rivière

IR

100

Publications

20.1K

Citations

50

H-Index

1990

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Kettering University

Isabelle Rivière is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1990–2025

100

Publications

100

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

Jae H. Park, Isabelle Rivière, Mithat Gönen et al. · New England Journal of Medicine · 2018 · 2.6K citations · Full text

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Marco L. Davila, Isabelle Rivière, Xiuyan Wang et al. · Science Translational Medicine · 2014 · 2.5K citations · Full text

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

Renier J. Brentjens, Marco L. Davila, Isabelle Rivière et al. · Science Translational Medicine · 2013 · 2.1K citations · Full text

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Renier J. Brentjens, Isabelle Rivière, Jae H. Park et al. · Blood · 2011 · 1.3K citations · Full text

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

John Maher, Renier J. Brentjens, Gertrude Gunset et al. · Nature Biotechnology · 2002 · 997 citations

, , +8

Rows per page

1–5 of 100